Multicenter Series Defines Post CAR T Enterocolitis Risk

A Nature Medicine study published online November 19 characterized immune effector cell-associated enterocolitis after BCMA CAR T, predominantly cilta-cel. This is an important safety signal in myeloma, not a new estimate of product-wide mortality.





